Composites based on nanosized particles of magnetite and natural microsized zeolite were prepared and their efficiency to adsorb arsenate from aqueous systems was evaluated through kinetic data and adsorption isotherms, considering the proportion of magnetic iron oxide, composite:solution ratio and zeolite particle size. A well-crystallized nanomagnetite with an averaged particle size of 50 nm when supported on zeolite was obtained; the nanomagnetite enhances the arsenate adsorption of zeolite. The composite prepared with a nanomagnetite:zeolite mass ratio of 0.43:1 and 0.30:1 presented on zeolite milled 20 and 120 min, respectively, showed a similar adsorption capacity as that observed for pure magnetite. Supported nanomagnetite prevents risks of the nanoparticles contamination. The smaller the mean particle size of zeolite the lower the mass proportion of nanomagnetite in the composite required to reach the maximum adsorptive efficiency. Acidic conditions improve arsenate remotion, in agreement with the development of positive surface charge in the composite.

In this work we present the synthesis and characterization of iron oxide nanoparticles (IONPs), which were structurally and magnetically characterized. The use of iron salts and an organic acid (l-serine or ascorbic acid) as precursors under solvothermal conditions yielded these coated IONPs. The powder X-ray diffraction pattern of FeO-1 and FeO-2 is consistent with hematite (α-Fe2O3) and hematite-maghemite ((α-Fe2O3/γ-Fe2O3) respectively. The TEM analysis permits to estimate an average size of 10 nm for the FeO-1 sample. The magnetic characterization of the samples through the M(H) plots showed a very low coercivity value for both samples, being 53 Oe for FeO-1 and 10 Oe for FeO-2, indicating the very weak ferromagnetic character of the synthesized iron oxide species. Even though both organic acids under solvothermal conditions permit to obtain coated IONPs in one pot reaction, l-serine produces a more narrow-size distribution.

Background: The progress in material science and the recent advances in biodegradable/biocompatible polymers and magnetic iron oxide nanoparticles have led to develop innovative diagnostic and therapeutic strategies for diseases based on multifunctional nanoparticles, which include contrast medium for magnetic resonance imaging, agent for hyperthermia and nanocarriers for targeted drug delivery. The aim of this work is to synthesize and characterize superparamagnetic iron oxide (magnetite), and to encapsulate them into poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles for biomedical applications. Results: The magnetite nanoparticles were confirmed by X-ray diffraction and exhibited a size of 22.3 ± 8.8 nm measured by transmission electron microscopy (TEM). Polymeric PHBV nanoparticles loaded with magnetite (MgNPs) were analyzed using dynamic light scattering and showed a size of 258.6 ± 35.7 nm and a negative zeta potential (-10.8 ± 3.5 mV). The TEM examination of MgNPs exhibited a spherical core-shell structure and the magnetic measurements showed in both, non-encapsulated magnetite and MgNPs, a superparamagnetic performance. Finally, the in vitro studies about the magnetic retention of MgNPs in a segment of small intestine of rats showed an active accumulation in the region of the magnetic field. Conclusions: The results obtained make the MgNPs suitable as potential magnetic resonance imaging contrast agents, also promoting hyperthermia and even as potential nanocarriers for site-specific transport and delivery of drugs.